Purchase by Vaczy Catherine M of 20000 shares of Genprex

GNPX Stock  USD 1.10  0.04  3.51%   
Slightly above 66 percent of all Genprex's investors are curious in acquiring. The analysis of the overall investor sentiment regarding Genprex suggests that a large number of traders are confidant. Genprex's investing sentiment can be driven by a variety of factors including economic data, Genprex's earnings reports, geopolitical events, and overall market trends.
  
Filed transaction by Genprex Inc officer. General open market or private purchase of non-derivative or derivative security

Read at macroaxis.com
Genprex insider trading alert for perchase of common stock by Vaczy Catherine M, EVP GC Chief Strategy Officer, on 24th of April 2023. This event was filed by Genprex Inc with SEC on 2023-04-24. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

Genprex's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Genprex's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Genprex Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Genprex can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Genprex Fundamental Analysis

We analyze Genprex's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Genprex using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Genprex based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Beta

Beta Comparative Analysis

Genprex is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.

Genprex Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Genprex stock to make a market-neutral strategy. Peer analysis of Genprex could also be used in its relative valuation, which is a method of valuing Genprex by comparing valuation metrics with similar companies.

Peers

Genprex Related Equities

RVPHWReviva Pharmaceuticals   23.53   
0%
100.0%
EYENEyenovia   19.05   
0%
80.0%
RNAZTranscode Therapeutics   11.76   
0%
49.0%
KODKodiak Sciences   4.92   
0%
20.0%
GLSIGreenwich Lifesciences   4.47   
0%
18.0%
MREOMereo BioPharma   1.09   
0%
4.0%
ELEVElevation Oncology   1.64   
6.0%
0%
CGTXCognition Therapeutics   2.27   
9.0%
0%
HEPAHepion Pharmaceuticals   3.70   
15.0%
0%
RVPHReviva Pharmaceuticals   8.06   
34.0%
0%
XFORX4 Pharmaceuticals   8.65   
36.0%
0%

Additional Tools for Genprex Stock Analysis

When running Genprex's price analysis, check to measure Genprex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genprex is operating at the current time. Most of Genprex's value examination focuses on studying past and present price action to predict the probability of Genprex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genprex's price. Additionally, you may evaluate how the addition of Genprex to your portfolios can decrease your overall portfolio volatility.